Stryker Acquires HyperBranch Medical Technology, Inc.

Register to receive a free US Market Report Suite for Wound and Tissue Management report synopsis and brochure

Stryker announced the acquisition of privately-held HyperBranch Medical Technology, Inc. for a total equity value of approximately $220 million in an all-cash transaction. HyperBranch is dedicated to developing medical devices based on its proprietary polymers and cross-linked hydrogels. Its Adherus AutoSpray Dural Sealant product is one of only two FDA-approved dural sealants on the market.

“The acquisition of HyperBranch supports our growth strategy within our Neurotechnology business,” said Spencer S. Stiles, Group President, Neurotechnology, Instruments, and Spine for Stryker. “The addition of Adherus to our cranial closure portfolio strengthens our position of excellence in the dural repair space and aligns with Stryker’s mission of making healthcare better.”

As a PMA approved and CE cleared hydrogel that is indicated for use as an adjunct to standard methods of dural repair to aid in creating a watertight closure of the dura, the Adherus product is highly complementary to Stryker’s Craniomaxillofacial division. The patent-protected sealant formulation, combined with a differentiated delivery system, is proven through clinical trials to provide clinically safe and effective dural closure.

The transaction is expected to have an immaterial impact on net earnings in 2018.

Sidley Austin LLP served as outside legal counsel for Stryker in connection with this transaction.


For Further Information

More on the wound tissue market in the US can be found in a series of reports published by iData Research entitled the US Market Report Suite for Wound and Tissue Management. The suite covers reports on the following markets: Wound Closure, Static Compression Therapy, Dynamic Compression Therapy, Advanced Dressings, Moist Dressings, Antimicrobial Dressings, Interactive Dressings, Non-Adherent Contact Layers, Traditional Wound Dressings, Hemostats, Tissue Sealants, Anti-Adhesion, and Negative Pressure Wound Therapy.

The iData report series on wound and tissue management covers the U.S., Japan, India, China, and 15 countries in Europe including Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, the United Kingdom, and Switzerland. Reports provide a comprehensive analysis including units sold, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about wound tissue management market data, register online or email us at for a US Market Report Suite for Wound and Tissue Management brochure and synopsis.

Leave a Reply